Tarsus Pharmaceuticals, Inc.
TARS
Jodie situation report
Tarsus Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.
- Revenue increased 69.4% versus the comparable filing period.
- TARS's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if TARS's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind TARS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
LIANYFiling-linked namepartnerFeb 23, 2026 ▾
“In March 2021, we entered into the China Out-License with LianBio Ophthalmology Limited (“LianBio”), granting exclusive commercial rights of TP-03 for the treatment of Demodex blepharitis and MGD within the China Territory.”
MRNAModerna, Inc.partnerFeb 23, 2026 ▾
“We are aware of vaccines currently under development including a multivalent recombinant protein vaccine, VLA-15, being developed by Valneva in partnership with Pfizer for Lyme disease; mRNA-based vaccine mRNA-1982/1975, being developed by Moderna and eliciti…”
Depended on by
HTGCHercules Capital, Inc.investeeOct 30, 2025 ▾
“The net realized gains (losses) were generated from gross realized gains of $2.8 million and $17.8 million respectively, for the three and nine month periods, primarily from the sale of our equity and warrant positions in Palantir Technologies, TransMedics Gr…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
TARS is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.